论文部分内容阅读
用拆分,复制及分红3招治疗“恐高症”引起的困境,仍只是基金公司的权宜之计。正如晨星中国王君言所言,克隆基金日后的规模如大举萎缩,难道要接着复制三号?或者又如银河证券王群航所言,假如投资者还是嫌分拆基金的净值高,是否还会有“二拆”、“三拆”、“N拆”之类层出不穷的创新呢?说到底,基金业的发展始终无法跨越“恐高”——将基金操作等同于普通消费品或股票操作——这一错误理念存在的历史阶段。祖国医学讲求“标本兼治”,在用以上3招治标的同时,基金公司和媒体都有责任从投资者和自身的长远利益出发,认真地思考如何引导投资者在纠正“恐高症”中获得成长这一历史性命题
The use of split, copy and bonus 3 strokes treatment of “psoriasis” caused by the plight of the fund company is still only an expedient measure. As Morningstar China Wang Junyan said, the size of the clone fund such as the massive decline in the future, do you want to then copy No. 3 Or another example Galaxy Securities Wang Qun said that if investors are still too high net worth of spin-off funds, whether there will be “two In the final analysis, the development of the fund industry has always failed to cross the ”fear of terror“ - the mistake of equating fund operations with ordinary consumer goods or stock operations History of the existence of the concept stage. At the same time, the fund companies and the media all have the responsibility to start from investors and their own long-term interests and seriously consider how to guide investors in correcting ”phobia" Growth of this historic proposition